Enzymatic Digestion of Cell-surface Heparan Sulfate Alters the Radiation Response in Triple-negative Breast Cancer Cells

Ferlay, 2021, Cancer statistics for the year 2020: An overview, Int J Cancer, 149, 778, 10.1002/ijc.33588 Yersal, 2014, Biological subtypes of breast cancer: Prognostic and therapeutic implications, World J Clin Oncol, 5, 412, 10.5306/wjco.v5.i3.412 Fragomeni, 2018, Molecular Subtypes and Local-Regional Control of Breast Cancer, Surg Oncol Clin N Am, 27, 95, 10.1016/j.soc.2017.08.005 Dent, 2007, Triple-negative breast cancer: Clinical features and patterns of recurrence, Clinical Cancer Research, 13, 4429, 10.1158/1078-0432.CCR-06-3045 Yin, 2020, Triple-negative breast cancer molecular subtyping and treatment progress, Breast Cancer Res, 22, 61, 10.1186/s13058-020-01296-5 Peinado-Serrano, 2022, Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors, Cancers (Basel), 14, 2202, 10.3390/cancers14092202 Darby, 2011, Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials, Lancet, 378, 1707, 10.1016/S0140-6736(11)61629-2 de Pasquale, 2019, Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses, Biochim Biophys Acta Mol Basis Dis, 1865, 10.1016/j.bbadis.2019.165539 Hassan, 2021, Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer, Cell Signal, 77, 10.1016/j.cellsig.2020.109822 Espinoza-Sánchez, 2020, Role of cell surface proteoglycans in cancer immunotherapy, Semin Cancer Biol, 62, 48, 10.1016/j.semcancer.2019.07.012 Hammond, 2014, The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumour microenvironment and opportunities for novel cancer therapeutics, Front Oncol, 4, 195, 10.3389/fonc.2014.00195 Hassan, 2013, Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation, FEBS J, 280, 2216, 10.1111/febs.12111 Ibrahim, 2012, Targeting of syndecan-1 by microRNA miR-10b promotes breast cancer cell motility and invasiveness via a Rho-GTPase- and E-cadherin-dependent mechanism, Int J Cancer, 131, E884, 10.1002/ijc.27629 Onyeisi, 2020, Heparan sulfate proteoglycans as targets for cancer therapy: a review, Cancer Biol Ther, 21, 1087, 10.1080/15384047.2020.1838034 Gomes, 2013, Heparan sulfate and heparanase as modulators of breast cancer progression, Biomed Res Int, 2013, 10.1155/2013/852093 Sanderson, 2005, Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies, J Cell Biochem, 96, 897, 10.1002/jcb.20602 Götte, 2011, The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1, Int J Cancer, 129, 2042, 10.1002/ijc.25856 Nagarajan, 2018, Heparan sulfate and Heparan Sulfate Proteoglycans in cancer initiation and progression, Front Endocrinol (Lausanne), 9, 483, 10.3389/fendo.2018.00483 Carlos-Reyes, 2021, Biological Adaptations of Tumor Cells to Radiation Therapy, Front Oncol, 11, 4804, 10.3389/fonc.2021.718636 Moncharmont, 2014, Radiation-enhanced cell migration/invasion process: A review, Crit Rev Oncol Hematol, 92, 133, 10.1016/j.critrevonc.2014.05.006 Vijaya Kumar, 2020, HS2ST1-dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior, Cancer Sci, 111, 2907, 10.1111/cas.14539 Nurcombe, 2000, The proliferative and migratory activities of breast cancer cells can be differentially regulated by heparan sulfates, J Biol Chem, 275, 30009, 10.1074/jbc.M003038200 Matsui, 2008, Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance, Cancer Res, 68, 190, 10.1158/0008-5472.CAN-07-3096 Katakam, 2020, Syndecan-1-Dependent Regulation of Heparanase Affects Invasiveness, Stem Cell Properties, and Therapeutic Resistance of Caco2 Colon Cancer Cells, Front Oncol, 10, 774, 10.3389/fonc.2020.00774 Faria-Ramos, 2021, Heparan Sulfate Glycosaminoglycans: (Un)Expected Allies in Cancer Clinical Management, Biomolecules, 11, 1, 10.3390/biom11020136 Yip, 2006, Therapeutic value of glycosaminoglycans in cancer, Mol Cancer Ther, 5, 2139, 10.1158/1535-7163.MCT-06-0082 Hammond, 2014, The role of heparanase and sulfatases in the modification of heparan sulfate proteoglycans within the tumour microenvironment and opportunities for novel cancer therapeutics, Front Oncol, 4, 195, 10.3389/fonc.2014.00195 Fux, 2009, Heparanase: busy at the cell surface, Trends Biochem Sci, 34, 511, 10.1016/j.tibs.2009.06.005 Yang, 2020, Heparanase from triplenegative breast cancer and platelets acts as an enhancer of metastasis, Int J Oncol, 57, 890 Sanderson, 2004, Heparan sulfate proteoglycans and heparanase–partners in osteolytic tumor growth and metastasis, Matrix Biol, 23, 341, 10.1016/j.matbio.2004.08.004 Ilan, 2006, Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis, Int J Biochem Cell Biol, 38, 2018, 10.1016/j.biocel.2006.06.004 Nagarajan, 2018, Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression, Front Endocrinol (Lausanne), 9, 483, 10.3389/fendo.2018.00483 Fedarko, 1989, Control of cell division in hepatoma cells by exogenous heparan sulfate proteoglycan, J Cell Physiol, 139, 287, 10.1002/jcp.1041390210 Masoudi-Khoram, 2020, Differential miRNAs expression pattern of irradiated breast cancer cell lines is correlated with radiation sensitivity, Scientific Reports, 2020, 1 Cohen, 2006, Heparanase promotes growth, angiogenesis and survival of primary breast tumors, Int J Cancer, 118, 1609, 10.1002/ijc.21552 Rubinfeld, 2011, Heparanase is highly expressed and regulates proliferation in GH-secreting pituitary tumor cells, Endocrinology, 152, 4562, 10.1210/en.2011-0273 Ostapoff, 2013, PG545, an angiogenesis and heparanase inhibitor, reduces primary tumor growth and metastasis in experimental pancreatic cancer, Mol Cancer Ther, 12, 1190, 10.1158/1535-7163.MCT-12-1123 Schulz, 2019, Cancer Stem Cells and Radioresistance: DNA Repair and Beyond, Cancers (Basel), 11, 862, 10.3390/cancers11060862 Arnold, 2020, The Role of Cancer Stem Cells in Radiation Resistance, Front Oncol, 10, 164, 10.3389/fonc.2020.00164 Ding, 2012, Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells, Biochem Biophys Res Commun, 426, 106, 10.1016/j.bbrc.2012.08.044 Kayal, 2021, Heparanase 2 (Hpa2) attenuates the growth of pancreatic carcinoma, Matrix Biol, 98, 21, 10.1016/j.matbio.2021.03.002 Sanderson, 2001, Heparan sulfate proteoglycans in invasion and metastasis, Semin Cell Dev Biol, 12, 89, 10.1006/scdb.2000.0241 Karamanos, 2018, Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics, Chem Rev, 118, 9152, 10.1021/acs.chemrev.8b00354 Li, 2016, Heparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cells, Oncotarget, 7, 11299, 10.18632/oncotarget.7170 Purushothaman, 2008, Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma, J Biol Chem, 283, 32628, 10.1074/jbc.M806266200 Qiao, 2022, Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies, Front Oncol, 12, 417, 10.3389/fonc.2022.775238 Troschel, 2021, Heparanase Expression Is Associated With Cancer Stem Cell Features and Radioresistance in Hodgkin's Lymphoma Cells, Anticancer Res, 41, 3299, 10.21873/anticanres.15117 Troschel, 2020, Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer, Int J Mol Sci, 21, 2169, 10.3390/ijms21062169 Li, 2017, Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1, Am J Cancer Res, 7, 234 Meirovitz, 2011, Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma, Cancer Res, 71, 2772, 10.1158/0008-5472.CAN-10-3402 de Pasquale, 2020, Heparan Sulfate Proteoglycan Signaling in Tumor Microenvironment, Int J Mol Sci, 21, 1, 10.3390/ijms21186588 Zhou, 2019, The roles of nuclear focal adhesion kinase (FAK) on Cancer: A focused review, J Exp Clin Cancer Res, 38, 250, 10.1186/s13046-019-1265-1 Hehlgans, 2012, Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling, Int J Radiat Oncol Biol Phys, 83, e669, 10.1016/j.ijrobp.2012.01.065 Shi, 2011, Heparan Sulfate Proteoglycans Mediate Interstitial Flow Mechanotransduction Regulating MMP-13 Expression and Cell Motility via FAK-ERK in 3D Collagen, PLoS One, 6, e15956, 10.1371/journal.pone.0015956 Nguemgo Kouam, 2019, The increased adhesion of tumor cells to endothelial cells after irradiation can be reduced by FAK-inhibition, Radiat Oncol, 14, 25, 10.1186/s13014-019-1230-3 Bolós, 2010, The dual kinase complex FAK-Src as a promising therapeutic target in cancer, Onco Targets Ther, 3, 83, 10.2147/OTT.S6909 Kim, 2015, Radiation promotes malignant phenotypes through SRC in breast cancer cells, Cancer Sci, 106, 78, 10.1111/cas.12574 Cohen-Kaplan, 2012, Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer, J Biol Chem, 287, 6668, 10.1074/jbc.M111.271346 Cohen-Kaplan, 2020, Heparanase Loosens E-Cadherin-Mediated Cell-Cell Contact via Activation of Src, Front Oncol, 10, 2, 10.3389/fonc.2020.00002 Spyrou A, Kundu S, Haseeb L, et al. Cancer Biology and Signal Transduction Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In vivo Tumor Growth. Published online 2017. doi:10.1158/1535-7163.MCT-16-0900. Yan, 2007, Irradiation-induced G2/M checkpoint response requires ERK1/2 activation, Oncogene, 26, 4689, 10.1038/sj.onc.1210268 Ciccarelli, 2018, Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo, J Cancer Res Clin Oncol, 144, 1685, 10.1007/s00432-018-2696-3 Schaue, 2015, Radiation and Inflammation, Semin Radiat Oncol, 25, 4, 10.1016/j.semradonc.2014.07.007 Goodall, 2014, Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4, PLoS One, 9, 10.1371/journal.pone.0109596 Multhoff, 2012, Radiation, inflammation, and immune responses in cancer, Front Oncol, 2, 58, 10.3389/fonc.2012.00058 Purushothaman, 2012, Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple Myeloma, J Biol Chem, 287, 41288, 10.1074/jbc.M112.391417 Arai, 1994, Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes, J Biol Chem, 269, 20388, 10.1016/S0021-9258(17)32004-5 Yang, 2019, CXCL1 stimulates migration and invasion in ER-negative breast cancer cells via activation of the ERK/MMP2/9 signaling axis, Int J Oncol, 55, 684 Zheng, 2020, IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation, Front Endocrinol (Lausanne), 11, 233, 10.3389/fendo.2020.00233 Gutter-Kapon, 2016, Heparanase is required for activation and function of macrophages, Proc Natl Acad Sci USA, 113, E7808, 10.1073/pnas.1611380113 Pasi, 2010, IL-8 and IL-6 Bystander Signalling in Human Glioblastoma Cells Exposed to Gamma Radiation, Anticancer Res, 30, 2769 Li, 2020, Low-Dose Radiation Promotes Invasion and Migration of A549 Cells by Activating the CXCL1/NF-κB Signaling Pathway, Onco Targets Ther, 13, 3619, 10.2147/OTT.S243914 Fett, 1985, Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells, Biochemistry, 24, 5480, 10.1021/bi00341a030 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Vlodavsky, 2001, Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis, J Clin Invest, 108, 341, 10.1172/JCI13662 Guo, 2021, Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma, Front Pharmacol, 12, 2225, 10.3389/fphar.2021.627935 Oh, 2014, Radiation-induced angiogenic signaling pathway in endothelial cells obtained from normal and cancer tissue of human breast, Oncogene, 33, 1229, 10.1038/onc.2013.70 Wang, 2022, The roles of osteoprotegerin in cancer, far beyond a bone player, Cell Death Discovery, 8, 1 Geerts, 2020, Osteoprotegerin: Relationship to Breast Cancer Risk and Prognosis, Front Oncol, 10, 462, 10.3389/fonc.2020.00462 Timmen, 2020, The heparan sulfate proteoglycan Syndecan-1 influences local bone cell communication via the RANKL/OPG axis, Scientific Reports, 10, 1, 10.1038/s41598-020-77510-3 Yang, 2010, Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL, Cancer Res, 70, 8329, 10.1158/0008-5472.CAN-10-2179 Li, 2016, Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis, J Biol Chem, 291, 24160, 10.1074/jbc.M116.751974 Farhad, 2020, The effect of low-level laser radiation and doxycycline on the levels of osteoprotegerin and receptor activator of nuclear factor kappa-B ligand, Lasers Med Sci, 35, 1975, 10.1007/s10103-020-02993-5 Kumar, 2014, HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression, Int J Cancer, 135, 2579, 10.1002/ijc.28921 Hampton, 2022, Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer, Mol Cancer Ther, 21, 271, 10.1158/1535-7163.MCT-20-0969 Potapenko, 2015, Glycan-related gene expression signatures in breast cancer subtypes; relation to survival, Mol Oncol, 9, 861, 10.1016/j.molonc.2014.12.013 Ashkani, 2016, Glycosyltransferase Gene Expression Profiles Classify Cancer Types and Propose Prognostic Subtypes, Sci Rep, 6, 26451, 10.1038/srep26451 Lanzi, 2018, Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity, Molecules, 23, 2915, 10.3390/molecules23112915 Horton, 2018, Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy, Int J Radiat Oncol Biol Phys, 100, 23, 10.1016/j.ijrobp.2017.08.025